Pricing Log in Create free account

Janux Therapeutics, Inc. (JANX) vs Seaport Therapeutics, Inc (SPTX)

Janux Therapeutics, Inc. and Seaport Therapeutics, Inc are both Biotechnology companies. Seaport Therapeutics, Inc is the larger, with a market value of $1.1B against $981.9M — 1.1× the size. Seaport Therapeutics, Inc has the higher net margin (0.00% vs −300.0%) and the lower return on invested capital (−88.1% vs 0.00%). Across the 12 metrics below, Janux Therapeutics, Inc. leads on 7 and Seaport Therapeutics, Inc on 5.

Valuation

Metric JANX SPTX Biotechnology median
P/E n/m n/m 10.60
P/S 33.41 n/m 9.40
P/B 1.22 2.85 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 5.00 n/m 9.02
Earnings yield (9.02%) (107.07%) (32.88%)
Free cash flow yield (4.87%) (8.47%) (23.13%)

Profitability

Metric JANX SPTX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (419.24%) 0.00% 0.00%
Net margin (299.95%) 0.00% 0.00%
Free cash flow margin (162.70%) 0.00% 0.00%
Return on equity (10.58%) (74.36%) (51.96%)
Return on assets (9.94%) (37.78%) (46.06%)
Return on invested capital 0.00% (88.12%) 0.00%

Growth

Metric JANX SPTX Biotechnology median
Revenue growth (TTM) 214.40% — 6.76%
EPS growth (last fiscal year) (42.97%) 36.55% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric JANX SPTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 17.69 17.48 4.97
Net debt to EBITDA 5.58 2.42 1.01

Dividend

Metric JANX SPTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric JANX SPTX Biotechnology median
Market cap 981.86m 1.09b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack